Загрузка...
Tumour response in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors – assessment of intra-tumour heterogeneity
Intra-tumour heterogeneity is a common molecular phenomenon in metastatic clear cell renal carcinoma (mRCC), representing the genetic complexity of a tumour with multiple metastatic sites. The present commentary discusses the observed phenomena of phenotypic intra-tumour heterogeneity in mRCC patien...
Сохранить в:
| Опубликовано в: : | BMC Med |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5141635/ https://ncbi.nlm.nih.gov/pubmed/27923360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-016-0754-8 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|